Despite poor financial performance and declining revenue, th...
Despite poor financial performance and declining revenue, the company's P/S ratio aligns with the industry, suggesting less bearish investors. However, if the P/S falls in line with recent negative growth rates, shareholders may face disappointment. A share price decline could be imminent given the industry's growth forecasts and the company's declining revenue.
Luoxin Pharmaceuticals Group Stock Co., Ltd.'s (SZSE:002793) 29% Share Price Surge Not Quite Adding Up
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment